Thermo Fisher Scientific reports $44.56 billion revenue for fiscal year ended December 31, 2025, up 3.9%

ยท TMO

Thermo Fisher Scientific reported revenue of $44.56 billion for the year ended December 31, 2025, an increase of 3.9% from the previous year ($42.88 billion).

For the same period it posted net income of $6.7 billion, up 5.8%, or $17.74 per diluted share (16.53 a year earlier).

That is a net margin of 15%.

On Sanad's AAOIFI Standard 21 screen, Thermo Fisher Scientific is currently compliant: interest-bearing debt is 16.3% of market capitalisation (limit 30%), and impure income is 2.2% of revenue (limit 5%).

Source: 10-K filed with the U.S. Securities and Exchange Commission on February 26, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Thermo Fisher Scientific news